David W. Liu

David W. Liu has over 18 years of experience in the pharmaceutical and biotechnology industry. Currently, they work as the Director of Compliance and Project Management at Aerium Therapeutics. Prior to this role, they were a Senior Inspection Readiness/Clinical Operations - Consultant at Regeneron from October 2019 to September 2022. David W. also served as a Senior Clinical Operations Specialist - Consultant at Sorrento Therapeutics, Inc. from January 2019 to October 2019.

David's previous positions include being a Senior Clinical Operations Specialist at Axovant Sciences from January 2016 to December 2018, and at Stemline Therapeutics, Inc. from August 2013 to January 2016. David W. was a Senior Clinical Trial Management Specialist at Delcath Systems, Inc. from August 2011 to June 2013.

Prior to these roles, David worked as a Senior Clinical Research Scientist at DWL Consulting Corporation, focusing on Forest Laboratories, from October 2009 to August 2011. David W. also served as the Assistant Director of Clinical Operations at Electro Optical Sciences from January 2008 to October 2009. David W. worked as a Senior Clinical Research Scientist/Manager at Boehringer Engelheim Pharmaceuticals from October 2007 to January 2008.

David's career in the pharmaceutical industry began at Novartis Pharmaceuticals Corporation, where they worked as a Senior Clinical Research Manager from October 2004 to October 2007.

David W. Liu earned a Bachelor of Science (BS) degree in Economics from Queens College, where they studied from 1999 to 2003.